ANTI-CONSUMER DOUBLE STANDARD REAPPEARS IN SUPPRESSION OF CANCER DATA

ANTI-CONSUMER DOUBLE STANDARD REAPPEARS IN SUPPRESSION OF CANCER DATA

Cancer patients are denied access to existing scientific information on "alternative" cancer therapies assembled under a publicly-funded research grant. The National Cancer Institute (NCI) paid Grace Monaco and associates $500,000 to develop the Evaluative Database on Unproven and Untested Cancer Remedies. The idea was to make the information available for PDQ (Physician's Data Query) and the NCI hotline 1-800-4 CANCER. Compilers of the database included information on the methods' scientific validity, costs, therapists' credentials, clinic locations, and evaluations by scientific and medical groups--the type of information cancer patients searching for answers need to have. The database remains unused in Monaco's files. She can't even give it away. Why not? (1) Fears of lawsuits by those it evaluates, despite the fact that no such lawsuit has ever been successful in the past. (2) Political pressure from influential people in Congress. It is clear that medical alternavists do not want patients to have freedom of choice, rather, the freedom to market anything they wish. (Probe (1/1/95). [Saul Green, PhD, used information from the database in his JAMA articles on Antineoplastons (1992;267:2924-8), Gerson therapy (1192;268:3224-7), and Immuno-augmentative Therapy (1993;270;1719-23).]

~~~~~~~~
Edited by William Jarvis, Ph.D., Professor of Public Health and Preventive Medicine, Loma Linda university Schools of Public Health and Medicine.

Share this with your friends